Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:33 pm Purchase |
2024-12-31 | 13G | Forte Biosciences, Inc. FBRX |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 640,770 9.990% |
640,770 (New Position) |
Filing History |
| 2024-02-14 4:54 pm Purchase |
2023-12-31 | 13G | Forte Biosciences, Inc. FBRX |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 145,219 9.990% |
145,219 (New Position) |
Filing History |
| 2023-02-14 10:52 am Sale |
2022-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,231,427 3.900% |
-396,982 (-15.10%) |
Filing History |
| 2022-05-11 4:03 pm Sale |
2022-05-09 | 13D | Exicure, Inc. XCUR |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 39,042 4.770% |
-2,625 (-6.30%) |
Filing History |
| 2022-03-14 09:29 am Sale |
2022-03-08 | 13D | Bicycle Therapeutics plc BCYC |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,408,259 4.800% |
-549,702 (-28.08%) |
Filing History |
| 2022-02-14 12:06 pm Sale |
2021-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 5.800% |
-36,000 (-1.35%) |
Filing History |
| 2022-01-03 09:26 am Sale |
2021-12-30 | 13G | TPG Pace Beneficial Finance Corp. TPGY |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 0 0.000% |
-4,957,302 (Position Closed) |
Filing History |
| 2021-04-09 11:50 am Purchase |
2021-03-31 | 13G | TPG Pace Beneficial Finance Corp. TPGY |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 4,957,302 14.200% |
4,957,302 (New Position) |
Filing History |
| 2021-02-16 12:09 pm Sale |
2020-12-31 | 13G | FARFETCH LTD FTCHQ |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 5,354,942 1.800% |
-12,716,435 (-70.37%) |
Filing History |
| 2020-11-12 09:11 am Unchanged |
2020-11-05 | 13D | Bicycle Therapeutics plc BCYC |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,957,961 9.200% |
0 (Unchanged) |
Filing History |
| 2020-07-20 09:51 am Unchanged |
2020-06-30 | 13D | Bicycle Therapeutics plc BCYC |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,957,961 10.800% |
0 (Unchanged) |
Filing History |
| 2020-05-29 09:21 am Purchase |
2020-05-29 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,664,409 7.400% |
2,664,409 (New Position) |
Filing History |